5Van Eerdewegh P, Little RD, Dupuis J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness [ J ]. Nature,2002,418 (6896) :426 - 430.
6Yoshinaka T,Nishii K,Yamada K,et al. Identification and charac- terization of novel mouse and human ADAM33s with potential met- alloprotease activity [ J ]. Gene,2002,282:275 - 278.
7Prim akoff P, My les DG. The ADAM gene tb.mily, surface pro- teins with adhesion and protease activity [ J]. T rends Genet, 2000, 16(2) : 83 -87.
8Jie ZJ,Jin ML,Cai YY,et al. The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflam- mation [ J ]. Respiratory Physiology & Neurobiology, 2009,168 : 289 - 294.
9Umland SP.Garlisi CG,Shah H,et al. Human ADAM33 messenger RNA expression profile and posttranscriptional Regulation [ J 1. Am J Respir Cell Mol Bi01,2009,29:571 - 582.
10Foley SC, Mogas AK, Olivenstein R, et al. Increased expression of ADAM33 and ADAM8 with disease progression in asthma[ J]. J Allergy clin Immunol, 2007, 119:863 - 871.
8Bikle D.Nonclassic actions of vitamin D.J Clin Endocrinol Metab,2009,94:26-34.
9Hansdottir S,Monick MM,Hinde SL,et al.Respiratory epithelial cells convert inactive vitamin D to it s active form:potential effects on host defense.J Immunol,2008,181:7090-7099.
10Gorman S,Judge MA,Burchell JT,et al.1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4 + CD25 + cells to modulate T helper type 2-driven asthmatic responses.Immunology,2010,130:181-192.
